0 Comments
0 Shares
2088 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Global Recombinant Vaccines Market Size AnalysisThe Recombinant Vaccines Market size was USD 9.94 Billion in 2023 and is expected to Reach USD 23.75 Billion by 2031 and grow at a CAGR of 11.5% over the forecast period of 2024-2031.The recombinant vaccines market is witnessing significant growth, driven by advancements in genetic engineering and biotechnology. These vaccines, which utilize recombinant DNA technology to produce antigens...0 Comments 0 Shares 377 Views 0 Reviews
- Influenza Vaccines Market Growth fueled by Advancements in Recombinant Vaccine TechnologiesThe influenza vaccines market has grown significantly over the recent past owing to the increasing disease prevalence and government initiatives to promote vaccination programs. Influenza, commonly known as flu, is an infectious respiratory illness caused by influenza viruses. Currently available influenza vaccines include the trivalent influenza vaccine (TIV) and quadrivalent influenza vaccine...0 Comments 0 Shares 315 Views 0 Reviews
- Recombinant Vaccines Market Size, Analysis and Forecast 2031The Recombinant Vaccines Market in 2023 is US$ 10.09 billion, and is expected to reach US$ 24.32 billion by 2031 at a CAGR of 11.60%. FutureWise Research published a report that analyzes Recombinant Vaccines Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...0 Comments 0 Shares 459 Views 0 Reviews
- Recombinant Vaccines Market Size, Trends, Demand Analysis 2022-2028The global recombinant vaccines market size was valued at USD 11,507.3 million in 2021 and is poised to grow at a significant CAGR of 5.3% during the forecast period 2022-28. Increased prevalence of infectious diseases and increased technological advancements boost the growth of the recombinant vaccine market. Furthermore, increased regulatory approvals of recombinant vaccines also drive the...0 Comments 0 Shares 1406 Views 0 Reviews